Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
[BCG vs interferon A for prevention of recurrence of superficial bladder cancer. A prospective randomized study].
Urologe A. 1994 Mar;33(2):133-7.
Urologe A. 1994.
PMID: 8178407
Clinical Trial.
German.
[Prediction of unplanned discontinuation of treatment in patients with castration-resistant prostate cancer-results from the IBuTu study].
Honecker F, Wedding U, Kallischnigg G, Schroeder A, Klier J, Frangenheim T, Weißbach L.
Honecker F, et al. Among authors: frangenheim t.
Urologe A. 2018 Aug;57(8):909-918. doi: 10.1007/s00120-018-0704-5.
Urologe A. 2018.
PMID: 29978302
Review.
German.
No abstract available.
Item in Clipboard
Risk factors for unplanned discontinuation of scheduled treatment in elderly patients with castration-resistant prostate cancer: results of the IBuTu study.
Honecker F, Wedding U, Kallischnigg G, Schroeder A, Klier J, Frangenheim T, Weißbach L.
Honecker F, et al. Among authors: frangenheim t.
J Cancer Res Clin Oncol. 2018 Mar;144(3):571-577. doi: 10.1007/s00432-017-2577-1. Epub 2018 Jan 4.
J Cancer Res Clin Oncol. 2018.
PMID: 29299751
Item in Clipboard
Prospective Evaluation of Neuromediator Dynamics in Castration-Resistant Prostate Cancer Patients During Docetaxel.
VON Hardenberg J, Schwartz M, Werner T, Fuxius S, Müller M, Frangenheim T, Bolenz C, Weiss C, Heinrich E.
VON Hardenberg J, et al. Among authors: frangenheim t.
Anticancer Res. 2017 Sep;37(9):5117-5124. doi: 10.21873/anticanres.11931.
Anticancer Res. 2017.
PMID: 28870943
Item in Clipboard
Cite
Cite